Holly Buckley

2 weeks ago | openlegalblogarchive.org | Holly Buckley

LLR Partners has announced the close of a new fund. The fund — LLR Equity Partners VII — closed at $2.45 billion. LLR, founded in 1999 and based in Philadelphia, makes majority and minority investments in lower middle market technology and healthcare businesses. Within healthcare, the firm pursues investments in healthcare IT, outsourced healthcare services, managed care and provider-based organizations.

3 weeks ago | openlegalblogarchive.org | Holly Buckley

Linden Capital Partners has announced the close of a new buyout fund. The fund — Linden Capital Partners VI — is the firm’s sixth buyout fund. It closed with $5.4 billion of commitments, surpassing its $4.5 billion target and initial $5 billion hard cap. Linden, based in Chicago, is a private equity firm focused exclusively on the healthcare industry.

Feb 3, 2025 | openlegalblogarchive.org | Holly Buckley |Kevin Madagan

By Kevin MadaganLatticework Capital Management (LCM) and Edgehill Management have completed a strategic investment in Life Science Connect (LSC), according to a news release. LSC, founded in 2014 and based in Pittsburgh, Pennsylvania, is a life science digital media company. LCM, founded in 2015 and based in Dallas, makes control equity investments in the lower middle market.

Jan 7, 2025 | mondaq.com | Holly Buckley

Frontier Growth has announced an investment in Nymbl Systems. Nymbl, founded in 2016 and based in Dublin,Ohio, is a provider of cloud-based practice management software fororthotics and prosthetics, complex rehabilitation technology, andhome medical equipment providers. Frontier, founded in 1999 and based inCharlotte, North Carolina, is a growth equity firm that invests invertical SaaS companies in the lower middle market.

Dec 9, 2024 | mondaq.com | Holly Buckley

Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics' PEGylation reagent manufacturing business. The business, which will be branded Gannet BioChem and continue to operate out of its facility in Huntsville, Alabama, develops, scales and manufactures polyethylene glycol (PEG) reagents, which are used in advanced biopharmaceutical and therapeutic products.